Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2025 ,inter alia, to consider and approve Stock Split ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has called a board meeting on August 22, 2025 to consider two major corporate actions. First, a stock split in the ratio of 1:10, meaning each existing equity share will be divided into 10 shares. Second, a bonus issue of up to 1:1, meaning shareholders may receive one free share for every share they currently hold. The company states the objective is to enhance liquidity, broaden the shareholder base, and improve affordability for retail investors. The insider trading window has been closed immediately and will reopen 48 hours after the board announces its decision. Record dates and final terms will be communicated separately once the board approves the proposals.
If approved, these actions will substantially increase the share count and likely improve liquidity and retail participation, though the share price will adjust downward proportionally after the split and bonus. This is generally seen as a positive governance signal, especially for a small-cap pharma stock.